Skip to main content
OpenTrials
Completed

NCT Number: NCT03457506

Intra-individual Comparison of Conventional and Digital PET/CT Scanners

In this study, the investigators will analyze the impact of digital PET/CT on the final diagnostic conclusion of the scan in patients with lung cancer, breast cancer, esophageal cancer and a group of mescellaneous cancers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Digestive System Diseases Digestive System Neoplasms Esophageal Cancer Esophageal Diseases Esophageal Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Head and Neck Neoplasms Lung Cancer Lung Diseases Lung Neoplasms Miscellaneous Neoplasm Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Isala

Zwolle, Overijssel, 8025AB, Netherlands

About this study

There will be a single injection of the PET radiopharmaceutical FDG, followed by a conventional PET/CT scan and a digital PET scan, in this order or vice versa.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

  • referred to Isala for a clinically indicated FDG-PET/CT scan
  • suspected or proven lung cancer, esophageal cancer, breast cancer or miscellaneous cancer, either as a primary diagnosis or follow-up study
  • signed informed consent

Exclusion criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • age < 18 years
  • incapacitated adults
  • prisoners
  • pregnant patients
  • unable to undergo two consecutive PET/CT scans

Treatment and study plan

Digital PET/CT scan

Diagnostic Test

The digital PET/CT scan will be acquired before or after the conventional PET/CT scan.

Primary outcomes

  1. Diagnostic outcome of the PET/CT study

    Time frame: approximately 2 hours

Secondary outcomes

  1. PET image quality

    Time frame: approximately 2 hours

Sponsors and collaborators

Lead sponsor

Isala

Other

Collaborators

  • Philips Healthcare

Registry information

Official study title

Intra-individual Patient-based Comparison of Conventional and Digital PET/CT Scanners

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 7, 2018
Registry last updated
Sep 19, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.